Condensed Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Underwritten Public Offering [Member]	Preferred Stock [Member] Series A Non-Voting Convertible Preferred Stock [Member]	Preferred Stock [Member] Series B Non-Voting Convertible Preferred Stock [Member]	Common Stock [Member]	Common Stock [Member] Underwritten Public Offering [Member]	Additional Paid-in Capital [Member]	Additional Paid-in Capital [Member] Underwritten Public Offering [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Accumulated Deficit [Member]
Beginning Balances at Dec. 31, 2022	$ 255,735		$ 65,830		$ 70		$ 601,153		$ (104)	$ (411,214)
Beginning Balances, Shares at Dec. 31, 2022			81,050		69,893,434
Conversion of preferred stock into common stock			$ (3,520)		$ 1		3,519
Conversion of preferred stock into common stock, Shares			(4,000)		1,000,000
Issuance of common stock under Employee Stock Purchase Plan	313						313
Issuance of common stock under Employee Stock Purchase Plan, Shares					39,228
Issuance of common stock upon exercise of stock options	132						132
Issuance of common stock upon exercise of stock options, Shares					14,128
Unrealized gains (losses) on marketable securities	120								120
Stock-based compensation expense	5,850						5,850
Net loss	(38,587)									(38,587)
Ending Balances at Mar. 31, 2023	223,563		$ 62,310		$ 71		610,967		16	(449,801)
Ending Balances, Shares at Mar. 31, 2023			77,050		70,946,790
Beginning Balances at Dec. 31, 2022	255,735		$ 65,830		$ 70		601,153		(104)	(411,214)
Beginning Balances, Shares at Dec. 31, 2022			81,050		69,893,434
Net loss	(82,663)
Ending Balances at Jun. 30, 2023	348,428		$ 62,310		$ 85		780,007		(97)	(493,877)
Ending Balances, Shares at Jun. 30, 2023			77,050		85,334,165
Beginning Balances at Mar. 31, 2023	223,563		$ 62,310		$ 71		610,967		16	(449,801)
Beginning Balances, Shares at Mar. 31, 2023			77,050		70,946,790
Issuance of common stock in underwritten public offering, net of offering costs of 10.7 million		$ 161,789				$ 14		$ 161,775
Issuance of common stock in underwritten public offering, net of offering costs of 10.7 million, Shares						14,375,000
Issuance of common stock upon exercise of stock options	102						102
Issuance of common stock upon exercise of stock options, Shares					12,375
Unrealized gains (losses) on marketable securities	(113)								(113)
Stock-based compensation expense	7,163						7,163
Net loss	(44,076)									(44,076)
Ending Balances at Jun. 30, 2023	348,428		$ 62,310		$ 85		780,007		(97)	(493,877)
Ending Balances, Shares at Jun. 30, 2023			77,050		85,334,165
Beginning Balances at Dec. 31, 2023	257,802		$ 60,035		$ 86		801,059		246	(603,624)
Beginning Balances, Shares at Dec. 31, 2023			74,465		86,124,249
Issuance of Series B Preferred Stock and common stock, net of issuance costs of $11.6 million, in connection with the Private Placement	213,416			$ 87,364	$ 18		126,034
Issuance of Series B Preferred Stock and common stock, net of issuance costs of $11.6 million, in connection with the Private Placement, Shares				12,280	17,717,997
Exchange of common stock for Series B Preferred Stock				$ 74,754	$ (8)		(74,746)
Exchange of common stock for Series B Preferred Stock, Shares				8,300	(8,300,000)
Issuance of common stock upon exercise of stock options	356						356
Issuance of common stock upon exercise of stock options, Shares					71,150
Unrealized gains (losses) on marketable securities	(285)								(285)
Stock-based compensation expense	9,393						9,393
Net loss	(58,348)									(58,348)
Ending Balances at Mar. 31, 2024	422,334		$ 60,035	$ 162,118	$ 96		862,096		(39)	(661,972)
Ending Balances, Shares at Mar. 31, 2024			74,465	20,580	95,613,396
Beginning Balances at Dec. 31, 2023	257,802		$ 60,035		$ 86		801,059		246	(603,624)
Beginning Balances, Shares at Dec. 31, 2023			74,465		86,124,249
Net loss	(117,298)
Ending Balances at Jun. 30, 2024	373,223		$ 60,035	$ 54,085	$ 109		980,108		(192)	(720,922)
Ending Balances, Shares at Jun. 30, 2024			74,465	6,868	109,343,224
Beginning Balances at Mar. 31, 2024	422,334		$ 60,035	$ 162,118	$ 96		862,096		(39)	(661,972)
Beginning Balances, Shares at Mar. 31, 2024			74,465	20,580	95,613,396
Conversion of preferred stock into common stock				$ (107,980)	$ 13		107,967
Conversion of preferred stock into common stock, Shares				(13,712)	13,712,000
Issuance of common stock upon exercise of stock options	109						109
Issuance of common stock upon exercise of stock options, Shares					17,828
Change in estimate on Private Placement issuance costs	(129)			$ (53)			(76)
Unrealized gains (losses) on marketable securities	(153)								(153)
Stock-based compensation expense	10,012						10,012
Net loss	(58,950)									(58,950)
Ending Balances at Jun. 30, 2024	$ 373,223		$ 60,035	$ 54,085	$ 109		$ 980,108		$ (192)	$ (720,922)
Ending Balances, Shares at Jun. 30, 2024			74,465	6,868	109,343,224